← Back to all signals
RESEARCH PAPER ANALYSIS

Pediatric non-nasopharyngeal head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results (SEER) program with review of the literature.

AI interpretation is pending for this paper.

Open original publication →
PMID39442194
JournalInternational journal of pediatric otorhinolaryngology
Publication Date2024-10-15
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Despite its prevalence in adults, head and neck squamous cell carcinoma (HNSCC) is considered a rare entity in pediatrics where lymphomas, neural tumors, and soft tissue sarcomas predominate in the head and neck. Given the association of squamous cell carcinoma with the human papillomavirus, a risk factor that may be present from birth, and the difficulties in staging this disease for prognostication in children, it is important to revisit nationally collected data for prevalence and outcomes assessments. OBJECTIVE: To examine a publicly available national database to describe the incidence, pathology, treatment, and survival of pediatric HNSCC. To review the available literature regarding management, outcomes, and risk factors for this disease process. METHODS: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) tumor database was queried to identify pediatric subjects ages 0 to 19 diagnosed HNSCC between 1973 and 2019. RESULTS: Two-hundred ninety-two cases were identified. Subjects were 62.7 % male (n = 183) and the average age was 15.4 years (range 2-19, median 16). Subjects were 65.8 % white (n = 192), 22.9 % black (n = 67), 8.9 % Asian/Pacific Islander (n = 26), 1 % American Indian (n = 3), and 1.4 % unknown (n = 4). The most common primary sites were nasopharynx (45.9 %), oral cavity (30.5 %), larynx (8.6 %), salivary gland (4.1 %), nasal cavity & paranasal sinus (3.4 %), and lip (2.7 %). There was no statistically significant difference between primary subsite and age, race, histologic grade, or extent of disease. The 5-year overall survival was 83.6 %. DISCUSSION: Head and neck squamous cell carcinoma is more likely to present in older children and is more prevalent in White populations. The nasopharynx is the most common subsite involved, which differs from adult populations in which non-nasopharyngeal subsites including the larynx, oral cavity, and oropharynx are most frequently affected. CONCLUSION: Head and neck squamous cell carcinoma is rare in pediatric patients but should not be overlooked by physicians in the differential diagnosis, particularly in teenagers. Further study is needed to determine whether this represents a unique entity or can be staged and treated according to adult guidelines.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 [Diagnosis and treatment of a patient with epithelioid sarcoma]. Khirurgiia 63.64 2 Median Diaphragmatic Cyst Radiologically Consistent with a Mesothelial Cyst in a Young Adult: A Case Report. Prague medical report 45.5 3 Epidemiology of Helicobacter pylori and Gastric Atrophy in Rural Southwestern Uganda: The ENIGMA Uganda Study. Helicobacter 63.5 4 Testicular self-examination in adolescents following childhood orchiopexy for cryptorchidism. Journal of pediatric urology 67.0 5 Pyogenic Granuloma in the Sinonasal Cavity: A Potential 38-Year Latency Following Foreign Body Entrapment. International medical case reports journal 49.0 6 Factors Associated With Perceived Cognitive Dysfunction in Patients With Primary Brain Tumors: The Utility of the Neuro-QoL Cognition Function Scale. Cancer medicine 62.5 7 Tumor Profile, Clinical Features, and Outcomes in Individuals With Constitutional Trisomy 8: A Systematic Review of Case Reports and Case Series. Genes, chromosomes & cancer 76.9 8 Use of digital technologies to deliver supportive care to adolescents and young adults following treatment for cancer. Current opinion in supportive and palliative care 62.44 9 The impact of a minor child's cancer diagnosis on parental work: a scoping review. Revista da Escola de Enfermagem da U S P 39.0 10 Identifying Risk Factors for PICU Mortality in Pediatric Cancer Patients: A 10-Year Retrospective Study. Journal of pediatric hematology/oncology 71.5 11 Recent trends in childhood, teenage and young adult cancer incidence in England (2001-2020). European journal of cancer (Oxford, England : 1990) 57.5 12 Beyond Contraindication-Based Selection: The Unmet Need for Predictive Biomarkers in First-Line Immunotherapy for Advanced HCC. Targeted oncology 81.47 13 Adjuvant volumetric modulated arc therapy for incompletely resected type II pleuropulmonary blastoma: a case report. Oxford medical case reports 55.14 14 SurgiCorr: A Physics-Based Computational Framework for Patient-Specific Surgical Corridor Planning in Brain Tumor Surgery. Operative neurosurgery (Hagerstown, Md.) 58.7 15 Chemotherapy for Spinal Cord Intramedullary Pediatric Low-Grade Glioma-A Systematic Literature Review. Pediatric blood & cancer 76.14 16 Albumin-Bilirubin Score Is Associated With Veno-Occlusive Disease-Related Mortality in Children Post-Hematopoietic Stem Cell Transplant. Pediatric blood & cancer 65.0 17 Bone Mineral Density After Contemporary Treatment for Acute Lymphoblastic Leukaemia: A Matched Cross-Sectional Study. Pediatric blood & cancer 69.64 18 Implementing a South-South Cooperation Model to Strengthen Early Diagnosis of Childhood Cancer in the Andean Subregion. Pediatric blood & cancer 66.5 19 Risk factors for subsequent thyroid neoplasms development in childhood cancer survivors. Endocrine-related cancer 69.8 20 Challenges with the PRETEXT staging system: a SIOPEL Radiology Group position paper. Pediatric radiology 56.4 21 Post-earthquake monitoring of drinking-water quality and health risk in Kahramanmaraş Province, Türkiye: a two-timepoint screening assessment. Environmental geochemistry and health 57.5 22 Swedish matched-cohort on the association between maternal polyendocrine metabolic ovarian syndrome and next-generation cancer-risk. JNCI cancer spectrum 64.0 23 Marked hypokalemia at presentation in an adolescent with ectopic ACTH syndrome secondary to a bronchial carcinoid tumor: a case report. Hormone research in paediatrics 48.7 24 Cancer incidence in the Ecuadorian Amazon: A retrospective study (1990-2019). PloS one 61.5 25 Dynamic Morphological Changes of Focal Choroidal Excavations in Bilateral Choroidal Osteoma. Retinal cases & brief reports 57.0 26 Complications of Central Venous Catheters in Egyptian Children and Adolescents With Malignancy: A Prospective Single-Center Observational Study. Journal of pediatric hematology/oncology 60.0 27 Utility and limitations of 18F-fluciclovine PET for biopsy targeting in a nonenhancing diffuse glioma with a gliomatosis cerebri-like growth pattern: illustrative case. Journal of neurosurgery. Case lessons 60.4 28 Aggressive behavioral outbursts as an atypical presentation of giant pediatric trigeminal schwannoma: illustrative case. Journal of neurosurgery. Case lessons 58.0 29 Effect of a comic book-based educational intervention on human papillomavirus vaccine knowledge and safety perception among girls aged 9-14 in Nigeria. Vaccine 69.1 30 Anti-CASPR2 antibody associated Morvan syndrome in adolescents: dramatic response to immunotherapy: a case series. Brain & development 65.4 31 Balancing Cancer Prevention and Psychosocial Development in Young Patients with High Skin Cancer Risk. Journal of the American Academy of Dermatology 47.5 32 Parental Refusal of the Best Treatment: Nudges and Trust in Pediatrics. Pediatrics 77.54
PATIENT-FRIENDLY SUMMARY

Pediatric non-nasopharyngeal head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results (SEER) program with review of the literature.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic